Barclays Initiates Coverage on Baxter International (NYSE:BAX)
Barclays began coverage on shares of Baxter International (NYSE:BAX – Free Report) in a report released on Thursday, Marketbeat reports. The brokerage issued an overweight rating and a $39.00 price target on the medical instruments supplier’s stock. BAX has been the topic of a number of other research reports. Stifel Nicolaus lowered their target price […]
Barclays began coverage on shares of Baxter International (NYSE:BAX – Free Report) in a report released on Thursday, Marketbeat reports. The brokerage issued an overweight rating and a $39.00 price target on the medical instruments supplier’s stock. BAX has been the topic of a number of other research reports. Stifel Nicolaus lowered their target price […]
